Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04402541
Title Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cleave Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
KU Clinical Research Center Fairway Kansas 66205 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
Weill Cornel Medical Center New York New York 10065 United States Details
Saint Francis Hospital Cancer Center Greenville North Carolina 29607 United States Details
Cleveland Clinic, Case Comprehensive Cancer Center Cleveland Ohio 44122 United States Details
MD Anderson Cancer Cancer Houston Texas 77030 United States Details
St. Vincent Hospital, Sydney, NSW Darlinghurst New South Wales 2010 Australia Details
Epworth Healthcare Melbourne Victoria 3002 Australia Details
Haematology Clinical Trials Unit, Royal Perth Hospital Perth Western Australia 6000 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field